CVCarlos L. J. Vrins

Carlos L. J. Vrins

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carlos L. J. Vrins has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • André van der Zee

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

    1 shared publication
  • Erik A. L. Biessen

    Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands

    1 shared publication
  • Ko Willems van Dijk

    Department of Human Genetics Leiden University Medical Center Leiden the Netherlands

    1 shared publication
  • Louis M. Havekes

    TNO Prevention and Health, Gaubius Laboratory, Leiden, The Netherlands

    1 shared publication
  • Martine Groenendijk

    TNO Prevention and Health, Gaubius Laboratory, Leiden, The Netherlands

    1 shared publication
  • Peter van Santbrink

    Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Znf202 Affects High Density Lipoprotein Cholesterol Levels and Promotes Hepatosteatosis in Hyperlipidemic Mice

    by Carlos L. J. Vrins, Ruud Out, Peter van Santbrink, André van der Zee, Tokameh Mahmoudi, Martine Groenendijk, Louis M. Havekes, Theo J. C. van Berkel, Ko Willems van Dijk, Erik A. L. Biessen

    The zinc finger protein Znf202 is a transcriptional suppressor of lipid related genes and has been linked to hypoalphalipoproteinemia. A functional role of Znf202 in lipid metabolism in vivo still remains to be established. We generated mouse Znf202 expression vectors, the functionality of which was established in several in vitro systems. Next, effects of adenoviral znf202 overexpression in vivo were determined in normo- as well as hyperlipidemic mouse models. Znf202 overexpression in mouse hepatoma cells mhAT3F2 resulted in downregulation of members of the Apoe/c1/c2 and Apoa1/c3/a4 gene cluster. The repressive activity of Znf202 was firmly confirmed in an apoE reporter assay and Znf202 responsive elements within the ApoE promoter were identified. Adenoviral Znf202 transfer to Ldlr−/− mice resulted in downregulation of apoe, apoc1, apoa1, and apoc3 within 24 h after gene transfer. Interestingly, key genes in bile flux (abcg5/8 and bsep) and in bile acid synthesis (cyp7a1) were also downregulated. At 5 days post-infection, the expression of the aforementioned genes was normalized, but mice had developed severe hepatosteatosis accompanied by hypercholesterolemia and hypoalphalipoproteinemia. A much milder phenotype was observed in wildtype mice after 5 days of hepatic Znf202 overexpression. Interestingly and similar to Ldl−/− mice, HDL-cholesterol levels in wildtype mice were lowered after hepatic Znf202 overexpression. Znf202 overexpression in vivo reveals an important role of this transcriptional regulator in liver lipid homeostasis, while firmly establishing the proposed key role in the control of HDL levels.